Tirz
Tirzepatide (Research Peptide)
For Research Use Only – Not for Human Consumption, Diagnostic, or Therapeutic Use. Tirzepatide is supplied strictly for laboratory and scientific research applications, such as in vitro and in vivo studies on dual incretin receptor agonism, metabolic regulation, insulin sensitivity, appetite control, body weight management, and obesity/diabetes models. All information below is for educational and research reference only.
What Is Tirzepatide?
Tirzepatide (LY3298176) is a synthetic 39-amino acid linear peptide that acts as a dual agonist of the glucose-dependent insulinotropic polypeptide (GIP) receptor and glucagon-like peptide-1 (GLP-1) receptor. It features a C20 fatty diacid moiety attached via a linker at lysine-20, along with non-natural amino acids (Aib) for enhanced stability and a prolonged half-life.
Why Researchers Choose Tirzepatide
Tirzepatide offers a powerful dual-agonist platform for investigating synergistic incretin signaling, advanced weight-loss mechanisms, and multi-target metabolic therapies.
Questions about specifications, COA, or research applications? Contact our support team.
All products are for research purposes only. Not intended for human use.


















